About this product

This product offers advanced liposomal iron and folic acid tablets specifically formulated for pregnancy and infant supplementation, serving as a vital nutritional support. The primary function is to deliver highly bioavailable iron and folic acid, crucial for maternal health during pregnancy and for the healthy development of infants. Key features include the innovative liposomal encapsulation technology, which enhances absorption and minimizes gastrointestinal side effects often associated with traditional iron supplements. While specific technical specifications and performance characteristics are not detailed, the formulation prioritizes efficacy and safety for these sensitive demographics. The tablets are constructed with high-quality, pharmaceutical-grade ingredients, ensuring purity and consistency, with a standard tablet finish designed for easy consumption. This product is typically available in standard tablet sizes suitable for oral administration. Its primary applications lie within the pharmaceutical and nutraceutical sectors, targeting the prenatal and infant nutrition markets. Typical industry use cases include formulation into finished pharmaceutical products or as a bulk ingredient for dietary supplements. Target buyers for this product are primarily pharmaceutical manufacturers, dietary supplement wholesalers, and specialized infant nutrition product distributors seeking premium ingredients. While specific quality standards or certifications are not provided, the product is intended for use in regulated markets, implying adherence to general pharmaceutical ingredient quality expectations. This product is suitable for international trade buyers due to its specialized formulation addressing a critical global health need, its potential for high demand in both developed and developing markets, and its focus on enhanced bioavailability for optimal health outcomes.